Rob Woods

731 total citations
8 papers, 291 citations indexed

About

Rob Woods is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Oncology. According to data from OpenAlex, Rob Woods has authored 8 papers receiving a total of 291 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Radiology, Nuclear Medicine and Imaging, 5 papers in Immunology and 3 papers in Oncology. Recurrent topics in Rob Woods's work include Monoclonal and Polyclonal Antibodies Research (5 papers), HER2/EGFR in Cancer Research (3 papers) and Toxin Mechanisms and Immunotoxins (3 papers). Rob Woods is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (5 papers), HER2/EGFR in Cancer Research (3 papers) and Toxin Mechanisms and Immunotoxins (3 papers). Rob Woods collaborates with scholars based in United States, South Korea and Canada. Rob Woods's co-authors include Herren Wu, Changshou Gao, Nazzareno Dimasi, Ryan Fleming, Binyam Bezabeh, Jay Harper, Shenlan Mao, Qianli Wang, R. James Christie and Ze‐Qi Xu and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Journal of Controlled Release.

In The Last Decade

Rob Woods

8 papers receiving 277 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rob Woods United States 7 147 137 83 71 40 8 291
Xavier Charest‐Morin Canada 11 109 0.7× 25 0.2× 63 0.8× 72 1.0× 36 0.9× 27 313
Eduardo E. Mundo United States 10 186 1.3× 335 2.4× 269 3.2× 61 0.9× 22 0.6× 12 483
Deni Taleski Australia 8 236 1.6× 63 0.5× 161 1.9× 176 2.5× 51 1.3× 11 393
Jerrard M. Hayes Ireland 10 412 2.8× 314 2.3× 27 0.3× 168 2.4× 62 1.6× 15 504
Yiling Mi United States 9 267 1.8× 62 0.5× 31 0.4× 114 1.6× 55 1.4× 14 387
Yune Z. Kunes United States 5 353 2.4× 225 1.6× 124 1.5× 83 1.2× 10 0.3× 8 472
Andreas Nechansky Austria 12 237 1.6× 201 1.5× 79 1.0× 205 2.9× 16 0.4× 23 446
Colleen M. Britain United States 7 546 3.7× 37 0.3× 69 0.8× 207 2.9× 31 0.8× 7 609
Yuki Fujiwara Japan 10 130 0.9× 60 0.4× 104 1.3× 86 1.2× 8 0.2× 21 315
Vladimir Rait United States 9 311 2.1× 72 0.5× 45 0.5× 18 0.3× 26 0.7× 12 385

Countries citing papers authored by Rob Woods

Since Specialization
Citations

This map shows the geographic impact of Rob Woods's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rob Woods with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rob Woods more than expected).

Fields of papers citing papers by Rob Woods

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rob Woods. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rob Woods. The network helps show where Rob Woods may publish in the future.

Co-authorship network of co-authors of Rob Woods

This figure shows the co-authorship network connecting the top 25 collaborators of Rob Woods. A scholar is included among the top collaborators of Rob Woods based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rob Woods. Rob Woods is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Du, Qun, Jodi L. Karnell, Xiaodong Xiao, et al.. (2019). Discovery and characterization of potent IL-21 neutralizing antibodies via a novel alternating antigen immunization and humanization strategy. PLoS ONE. 14(1). e0211236–e0211236. 5 indexed citations
2.
Kroh, Heather K., Ramyavardhanee Chandrasekaran, Rob Woods, et al.. (2017). Use of a neutralizing antibody helps identify structural features critical for binding of Clostridium difficile toxin TcdA to the host cell surface. Journal of Biological Chemistry. 292(35). 14401–14412. 10 indexed citations
3.
Kroh, Heather K., Ramyavardhanee Chandrasekaran, Rob Woods, et al.. (2017). A neutralizing antibody that blocks delivery of the enzymatic cargo of Clostridium difficile toxin TcdB into host cells. Journal of Biological Chemistry. 293(3). 941–952. 27 indexed citations
4.
Christie, R. James, Ryan Fleming, Binyam Bezabeh, et al.. (2015). Stabilization of cysteine-linked antibody drug conjugates with N-aryl maleimides. Journal of Controlled Release. 220(Pt B). 660–670. 102 indexed citations
5.
Nyborg, Andrew C., Anna Zacco, Rachel Ettinger, et al.. (2015). Development of an antibody that neutralizes soluble IgE and eliminates IgE expressing B cells. Cellular and Molecular Immunology. 13(3). 391–400. 45 indexed citations
6.
Dimasi, Nazzareno, Ryan Fleming, Carl Hay, et al.. (2015). Development of a Trispecific Antibody Designed to Simultaneously and Efficiently Target Three Different Antigens on Tumor Cells. Molecular Pharmaceutics. 12(9). 3490–3501. 17 indexed citations
7.
Buchanan, Andrew, Rob Woods, Nicholas Harn, et al.. (2013). Engineering a therapeutic IgG molecule to address cysteinylation, aggregation and enhance thermal stability and expression. mAbs. 5(2). 255–262. 56 indexed citations
8.
Bruckheimer, Elizabeth, Christine Fazenbaker, Sandra Gallagher, et al.. (2009). Antibody-Dependent Cell-Mediated Cytotoxicity Effector-Enhanced EphA2 Agonist Monoclonal Antibody Demonstrates Potent Activity against Human Tumors. Neoplasia. 11(6). 509–IN2. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026